Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glutamate receptor subunit AMPA type 1 (GluA1) is one of four core subunits (GluA1–GluA4) that assemble as homo- or hetero-tetrameric complexes to form the AMPA subtype of ionotropic glutamate receptors, which are ligand-gated cation channels mediating fast excitatory synaptic transmission in the central nervous system[1][2][4][5]. Upon glutamate binding, these receptors conduct Na⁺ and, depending on subunit composition, Ca²⁺ ions into the postsynaptic neuron, thereby initiating depolarization and synaptic signaling[1][2][4][5]. GluA1-containing AMPA receptors are particularly important for activity-dependent synaptic insertion during long-term potentiation (LTP), a cellular correlate of learning and memory, and are dynamically regulated via auxiliary proteins (e.g., TARPs, CNIH, GSG1L) that modulate trafficking, localization, and channel kinetics[1][2][3][4]. Dysregulation of GluA1 is implicated in several neurological and psychiatric conditions, and AMPARs are explored as drug targets for epilepsy, neurodegeneration, and other brain disorders[2][4][5].
Competitive antagonism (block glutamate binding), Non-competitive antagonism (stabilize closed/inactive channel state), Allosteric modulation (alter gating kinetics or channel conductance), Channel blocking (directly occlude the ion pore)
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glutamate receptor subunit AMPA type 1 (GluA1).